Trial registration: The trial is registered at clinicaltrials.gov (identifier: NCT02249871). Supplemental data for this article can be accessedhere. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY 2018, VOL. 14, NO. 8, 869–877 https://doi.org/10.1080/17425255.2018.1488965 © 2018 Informa UK Limited, trading as Taylor & Francis Group2. Patients and methods An independent ethics committee, Landesamt für Gesundheit und Soziales, Berlin, approved the protocol. All subjects pro- vided written, informed consent. The trial was conducted in accordance with Good Clinical Practice, the Declaration of Helsinki, and US Food and Drug Administration (FDA)/ European Medicines Agency (EMA) guidelines for drug-drug interaction studies [13,14]. 2.1. Trial population Healthy male and female subjects aged 18 to 75 years and with a body mass index of 20.0 to 29.9 kg/m2 were eligible to participate if they were in good general health, based on medical history, physical examination, and assessment of vital signs, electrocardiogram, and laboratory safety tests.